ID   Dunatis
AC   CVCL_QW68
SY   DUNATIS
DR   Wikidata; Q54831590
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RX   PubMed=7919343;
RX   PubMed=9444937;
RX   PubMed=10071072;
CC   Doubling time: 5-7 days (PubMed=9444937).
CC   Sequence variation: Gene fusion; HGNC; HGNC:76; ABL1 + HGNC; HGNC:1014; BCR; Name(s)=BCR-ABL1, BCR-ABL (PubMed=10071072).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C114819; Adult B acute lymphoblastic leukemia with t(9;22)(q34.1;q11.2) BCR-ABL1
DI   ORDO; Orphanet_585909; B-lymphoblastic leukemia/lymphoma with t(9;22)(q34.1;q11.2)
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   67Y
CA   Cancer cell line
DT   Created: 15-11-17; Last updated: 19-12-24; Version: 11
//
RX   DOI=10.1016/B978-0-12-221970-2.50457-5;
RA   Drexler H.G.;
RT   "The leukemia-lymphoma cell line factsbook.";
RL   (In book) ISBN 9780122219702; pp.1-733; Academic Press; London; United Kingdom (2001).
//
RX   PubMed=7919343; DOI=10.1182/blood.V84.7.2253.2253;
RA   Renard N., Duvert V., Banchereau J., Saeland S.;
RT   "Interleukin-13 inhibits the proliferation of normal and leukemic
RT   human B-cell precursors.";
RL   Blood 84:2253-2260(1994).
//
RX   PubMed=9444937; DOI=10.1016/S0145-2126(97)00099-4;
RA   Renard N., Harada N., Callet-Bauchu E., Miyajima A., Duvert V.,
RA   Banchereau J., Saeland S.;
RT   "Heterogeneity of the inhibitory effects of IL-4 in two novel B
RT   lineage acute lymphoblastic leukemia cell lines.";
RL   Leuk. Res. 21:1037-1046(1997).
//
RX   PubMed=10071072; DOI=10.1016/S0145-2126(98)00171-4;
RA   Drexler H.G., MacLeod R.A.F., Uphoff C.C.;
RT   "Leukemia cell lines: in vitro models for the study of Philadelphia
RT   chromosome-positive leukemia.";
RL   Leuk. Res. 23:207-215(1999).
//